147 related articles for article (PubMed ID: 34627443)
1. [Enhanced Autophagy Suppresses Proplatelet Formation in Pediatric Immune Thrombocytopenia].
Wang Q; Li Y; Feng T; Feng X; Ji ZH; Ji XQ; Shao XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1577-1581. PubMed ID: 34627443
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation.
Wang Q; Wei J; Jia X; Feng X; Ji Z; Ji X; Shao X
BMC Pediatr; 2022 Mar; 22(1):164. PubMed ID: 35354403
[TBL] [Abstract][Full Text] [Related]
3. Immune thrombocytopenia induces autophagy and suppresses apoptosis in megakaryocytes.
Liu Z; Mei T
Mol Med Rep; 2018 Oct; 18(4):4016-4022. PubMed ID: 30106156
[TBL] [Abstract][Full Text] [Related]
4. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
5. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
[TBL] [Abstract][Full Text] [Related]
6. The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.
Wang Y; Guo Y; Zhang X; Zhao H; Zhang B; Wu Y; Zhang J
RNA Biol; 2021 Nov; 18(11):1953-1968. PubMed ID: 33586614
[TBL] [Abstract][Full Text] [Related]
7. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
[TBL] [Abstract][Full Text] [Related]
8. Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia.
Rivière É; Viallard JF; Guy A; Kilani B; Vieira-Dias J; Pons AC; Couffinhal T; Pellegrin JL; James C
Br J Haematol; 2015 Aug; 170(3):408-15. PubMed ID: 25873418
[TBL] [Abstract][Full Text] [Related]
9. Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura.
Uçar C; Oren H; Irken G; Ateş H; Atabay B; Türker M; Vergin C; Yaprak I
Eur J Haematol; 2003 Jun; 70(6):347-52. PubMed ID: 12756015
[TBL] [Abstract][Full Text] [Related]
10. Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice.
Eckly A; Rinckel JY; Laeuffer P; Cazenave JP; Lanza F; Gachet C; Léon C
J Thromb Haemost; 2010 Oct; 8(10):2243-51. PubMed ID: 20695978
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
[TBL] [Abstract][Full Text] [Related]
12. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
[TBL] [Abstract][Full Text] [Related]
13. The Value of Combined Detection of Megakaryocyte and Platelet Parameters for the Diagnosis of Primary Immune Thrombocytopenia.
Wang W; Tao S; Zhang X; Wang W; Xu Y; Liang W
Clin Appl Thromb Hemost; 2022; 28():10760296221106779. PubMed ID: 35924375
[No Abstract] [Full Text] [Related]
14. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia.
Parker RI; Siegel RS; Ratajczak MZ; Gewirtz AM
J Pediatr Hematol Oncol; 1998; 20(3):196-201. PubMed ID: 9628429
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
16. [A study on micromegakaryocyte in children with idiopathic thrombocytopenic purpura].
Shi XD; Hu T; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):192-5. PubMed ID: 15144713
[TBL] [Abstract][Full Text] [Related]
17. The ultrastructure of the megakaryocytes in idiopathic thrombocytopenic purpura (ITP) in relation to thrombokinetics.
Ridell B; Branehög I
Pathol Eur; 1976; 11(3):179-87. PubMed ID: 988533
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte apoptosis in immune thrombocytopenia.
Vrbensky JR; Nazy I; Toltl LJ; Ross C; Ivetic N; Smith JW; Kelton JG; Arnold DM
Platelets; 2018 Nov; 29(7):729-732. PubMed ID: 29787328
[TBL] [Abstract][Full Text] [Related]
19. Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation.
Takahashi R; Sekine N; Nakatake T
Blood; 1999 Mar; 93(6):1951-8. PubMed ID: 10068668
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocyte growth in vitro predicts outcome in idiopathic thrombocytopenic purpura.
Gerritsma H; Schmid A; Luethy AR; Leibundgut K; Gugler E; Wagner HP; Hirt A
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):194-9. PubMed ID: 8037336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
